期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
宫颈癌中P2RX1的表达与肿瘤浸润的相关性分析 被引量:4
1
作者 于运亮 封建凯 +1 位作者 姜杰 李婷 《标记免疫分析与临床》 CAS 2022年第2期301-308,348,共9页
目的探讨嘌呤能受体(purinergic receptor,P2RX1)与宫颈癌(cervical squamous cell carcinoma and endocervical adenocarcinoma,CESC)预后及免疫浸润的相关性。方法利用生物信息学技术分析CESC中P2RX1的表达,利用GEPIA 2.0、Kaplan-Mei... 目的探讨嘌呤能受体(purinergic receptor,P2RX1)与宫颈癌(cervical squamous cell carcinoma and endocervical adenocarcinoma,CESC)预后及免疫浸润的相关性。方法利用生物信息学技术分析CESC中P2RX1的表达,利用GEPIA 2.0、Kaplan-Meier plotter、MethSurv等数据库探索P2RX1的表达及甲基化与患者的预后关系,利用LinkedOmics、STRING、Cytoscape等工具进行富集分析并筛选核心基因(Hub gene),使用TIMER 2.0、R软件等工具分析P2RX1的表达与肿瘤免疫细胞浸润、免疫检查点、免疫/基质评分等的相关性。结果P2RX1在CESC中表达下调(P<0.01),P2RX1高表达的患者预后较好(P<0.05)。CESC中cg22506042等CpG位点甲基化水平较高,cg00161225等甲基化水平与患者预后相关。与P2RX1共表达的基因主要有FCRL5、CD79A等,主要富集于细胞因子等信号通路;主要参与淋巴细胞分化、T/B活化细胞等过程。筛选的Hub基因主要包括CD19、CD79B等,几乎均与CESC预后相关。P2RX1的表达与肿瘤纯度及多种免疫细胞尤其是B细胞浸润有关,与免疫/基质评分、CTLA-4、PD-1、CD27等多个免疫检查点呈正相关关系(P<0.001)。结论P2RX1低表达的CESC患者预后不良,其有望成为CESC诊断和免疫治疗的新靶点。 展开更多
关键词 p2rx1 宫颈癌 表达 预后 免疫浸润
暂未订购
Correlations between P2RX1 Expression and Gastrointestinal Cancers Prognosis and Immune Infiltration Based on Bioinformatics Analysis
2
作者 Ting Li Jiankai Feng +4 位作者 Pihong Yan Hongwei Tan Lili Wang Qiang Li Yunliang Yu 《Proceedings of Anticancer Research》 2021年第6期1-15,共15页
This study was conducted to explore the correlations between the expression,methylation,and various clinicopathological factors of purinergic P2X1 receptor(P2RX1)and the prognosis of patients with gastrointestinal tum... This study was conducted to explore the correlations between the expression,methylation,and various clinicopathological factors of purinergic P2X1 receptor(P2RX1)and the prognosis of patients with gastrointestinal tumors.The Cancer Genome Atlas(TCGA)and the Genotype-Tissue Expression(GTEx)databases were used to analyze the expression of P2RX1 in different types of gastrointestinal cancers.Kaplan-Meier analysis and univariate Cox regression analysis were used to analyze the correlations between P2RX1 expression and the prognosis of various gastrointestinal tumors.Correlations between P2RX1 expression and N6 methyladenine(m6A)-related genes as well as immune checkpoint genes were analyzed by R packages(R version:4.0.3)based on TCGA database.The association between P2RX1 methylation level and the prognosis of patients with gastrointestinal cancers was analyzed using the MethSurv database.In order to explore the biological functions of P2RX1 in hepatocellular carcinoma,the Kyoto Encyclopedia of Genes and Genomes(KEGG)and Gene Ontology(GO)enrichment analysis were carried out using R software.In order to evaluate the correlations between P2RX1 and tumor immune infiltration,Spearman correlation test was performed.The correlations between P2RX1 expression and immune score as well as immune checkpoint genes were analyzed based on TCGA and Tumor Immune Estimation Resource(TIMER)databases.The expression of P2RX1 was found to be significantly downregulated in gastrointestinal tumors except in cholangiocarcinoma(P<0.05).High expression of P2RX1 tended to present better prognosis in hepatocellular carcinoma(P<0.05).It was noted that cg06475633 of P2RX1 presented a higher methylation level compared with other CpG sites in hepatocellular carcinoma.Overall,six CpGs of P2RX1 were associated with significant prognosis in patients with hepatocellular carcinoma(P<0.05).Among all the 20 m6A-related genes,Wilms'tumor 1-associating protein(WTAP)was the most strongly correlated with P2RX1 in hepatocellular carcinoma.Gene enrichment analysis showed that P2RX1 is widely involved in the proliferation,activation,organization,and differentiation of various immune cells.After investigating the TIMER database,P2RX1 was found to be tightly correlated with immune infiltrating cells in gastrointestinal tumors,especially with dendritic cells.Moreover,P2RX1 was found to be strongly positively associated with programmed cell death 1(PD1),programmed death-ligand 1(PD-L1),and cytotoxic T-lymphocyte-associated protein 4(CTLA4)in hepatocellular carcinoma(P<0.05).In conclusion,the dual role of P2RX1 in cancers and its involvement in the recruitment as well as regulation of tumor infiltrating cells in gastrointestinal cancers may be appreciated through this study. 展开更多
关键词 p2rx1 Gastrointestinal cancers PROGNOSIS METHYLATION Tumor immune infiltration
暂未订购
嘌呤能受体X1与肺腺癌预后及免疫细胞浸润的相关性研究 被引量:5
3
作者 于运亮 王莉莉 +1 位作者 李婷 封建凯 《癌变·畸变·突变》 CAS 2022年第5期353-360,365,共9页
目的:探索嘌呤能受体X1(purinergic receptor,P2RX1)与肺腺癌(LUAD)患者预后及免疫细胞浸润的相关性。方法:利用生物信息学技术分析非小细胞肺癌中P2RX1的表达及其甲基化与患者预后的关系,对P2RX1共表达基因进行富集分析并筛选核心基因... 目的:探索嘌呤能受体X1(purinergic receptor,P2RX1)与肺腺癌(LUAD)患者预后及免疫细胞浸润的相关性。方法:利用生物信息学技术分析非小细胞肺癌中P2RX1的表达及其甲基化与患者预后的关系,对P2RX1共表达基因进行富集分析并筛选核心基因。利用TIMER 2.0数据库、R软件等分析P2RX1与免疫细胞、免疫检查点、免疫基质评分等的相关性。结果:P2RX1在LUAD中表达下调,低表达P2RX1的患者预后较差(P<0.05),且P2RX1与肿瘤纯度、分期等临床病理因素有关(P<0.05)。P2RX1的表达与肺鳞癌患者预后无明显相关。Cg06475633等P2RX1 CpG位点甲基化与患者预后相关。P2RX1共表达基因主要富集于免疫细胞活化、分化等通路和生物学进程,核心基因主要包括BTK、IKZF1等。P2RX1的表达与B细胞浸润、免疫/基质评分、PD-1、CTLA-4等多个免疫检查点显著相关(P<0.05)。结论:P2RX1有望成为LUAD诊断和免疫治疗的新靶点。 展开更多
关键词 嘌呤能受体X1 肺腺癌 数据库 预后
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部